Davide Bonazzi
Illustrator
From this contributor
Company on brink takes psilocybin to trial for fragile X syndrome
The phase 2A trial has its detractors despite positive animal results and is being sponsored by a company that is struggling financially.
Company on brink takes psilocybin to trial for fragile X syndrome
Explore more from The Transmitter
Snoozing dragons stir up ancient evidence of sleep’s dual nature
Deep-sleep cycling between brain waves of higher and lower amplitude dates far back on the evolutionary tree, according to a new comparative study of mammals and reptiles.
Snoozing dragons stir up ancient evidence of sleep’s dual nature
Deep-sleep cycling between brain waves of higher and lower amplitude dates far back on the evolutionary tree, according to a new comparative study of mammals and reptiles.
The Transmitter’s most-read neuroscience book excerpts of 2025
Books by Nachum Ulanovsky, Nicole Rust, and Andrew Iwaniuk and Georg Striedter made the list of some of the year's most engaging neuroscience titles.
The Transmitter’s most-read neuroscience book excerpts of 2025
Books by Nachum Ulanovsky, Nicole Rust, and Andrew Iwaniuk and Georg Striedter made the list of some of the year's most engaging neuroscience titles.
Neuroscience’s leaders, legacies and rising stars of 2025
Here are seven stories from the past year about some of the field’s most engaging figures.
Neuroscience’s leaders, legacies and rising stars of 2025
Here are seven stories from the past year about some of the field’s most engaging figures.